NO20080006L - Meget selektive serotonin og norepinefrin dobbelte reopptaksinhibitorer og deres anvendelse - Google Patents
Meget selektive serotonin og norepinefrin dobbelte reopptaksinhibitorer og deres anvendelseInfo
- Publication number
- NO20080006L NO20080006L NO20080006A NO20080006A NO20080006L NO 20080006 L NO20080006 L NO 20080006L NO 20080006 A NO20080006 A NO 20080006A NO 20080006 A NO20080006 A NO 20080006A NO 20080006 L NO20080006 L NO 20080006L
- Authority
- NO
- Norway
- Prior art keywords
- syndrome
- disorder
- anxiety
- reuptake inhibitors
- fibromyalgia
- Prior art date
Links
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 title abstract 4
- 229940076279 serotonin Drugs 0.000 title abstract 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 title 1
- 229960002748 norepinephrine Drugs 0.000 title 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 title 1
- 239000003775 serotonin noradrenalin reuptake inhibitor Substances 0.000 title 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 3
- 230000036506 anxiety Effects 0.000 abstract 3
- 206010008874 Chronic Fatigue Syndrome Diseases 0.000 abstract 2
- 208000001640 Fibromyalgia Diseases 0.000 abstract 2
- ZPUCINDJVBIVPJ-LJISPDSOSA-N cocaine Chemical compound O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1=CC=CC=C1 ZPUCINDJVBIVPJ-LJISPDSOSA-N 0.000 abstract 2
- 208000029766 myalgic encephalomeyelitis/chronic fatigue syndrome Diseases 0.000 abstract 2
- 208000008811 Agoraphobia Diseases 0.000 abstract 1
- 208000007848 Alcoholism Diseases 0.000 abstract 1
- 208000000103 Anorexia Nervosa Diseases 0.000 abstract 1
- 208000036864 Attention deficit/hyperactivity disease Diseases 0.000 abstract 1
- 206010003805 Autism Diseases 0.000 abstract 1
- 208000020706 Autistic disease Diseases 0.000 abstract 1
- 206010006550 Bulimia nervosa Diseases 0.000 abstract 1
- 208000022497 Cocaine-Related disease Diseases 0.000 abstract 1
- 206010013954 Dysphoria Diseases 0.000 abstract 1
- 208000033830 Hot Flashes Diseases 0.000 abstract 1
- 206010060800 Hot flush Diseases 0.000 abstract 1
- 208000008589 Obesity Diseases 0.000 abstract 1
- 208000021384 Obsessive-Compulsive disease Diseases 0.000 abstract 1
- 208000018737 Parkinson disease Diseases 0.000 abstract 1
- 208000003782 Raynaud disease Diseases 0.000 abstract 1
- 208000012322 Raynaud phenomenon Diseases 0.000 abstract 1
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 208000000323 Tourette Syndrome Diseases 0.000 abstract 1
- 201000007930 alcohol dependence Diseases 0.000 abstract 1
- 208000030963 borderline personality disease Diseases 0.000 abstract 1
- 229960003920 cocaine Drugs 0.000 abstract 1
- 201000006145 cocaine dependence Diseases 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 206010012601 diabetes mellitus Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 208000035475 disorder Diseases 0.000 abstract 1
- 206010013663 drug dependence Diseases 0.000 abstract 1
- 230000009977 dual effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 208000035231 inattentive type attention deficit hyperactivity disease Diseases 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000002767 noradrenalin uptake inhibitor Substances 0.000 abstract 1
- 229940127221 norepinephrine reuptake inhibitor Drugs 0.000 abstract 1
- 235000020824 obesity Nutrition 0.000 abstract 1
- 208000019906 panic disease Diseases 0.000 abstract 1
- 208000028173 post-traumatic stress disease Diseases 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 201000000980 schizophrenia Diseases 0.000 abstract 1
- 239000003772 serotonin uptake inhibitor Substances 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 230000001457 vasomotor Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/06—Anti-spasmodics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/52—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups or amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Addiction (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Urology & Nephrology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69966505P | 2005-07-15 | 2005-07-15 | |
| PCT/US2006/026991 WO2007011594A2 (fr) | 2005-07-15 | 2006-07-13 | Inhibiteur double hautement selectif de recaptage de la serotonine et de la noradrenaline et son utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20080006L true NO20080006L (no) | 2008-02-01 |
Family
ID=37453209
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20080006A NO20080006L (no) | 2005-07-15 | 2008-01-02 | Meget selektive serotonin og norepinefrin dobbelte reopptaksinhibitorer og deres anvendelse |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20070015828A1 (fr) |
| EP (1) | EP1904434A2 (fr) |
| JP (1) | JP2009501229A (fr) |
| KR (1) | KR20080034921A (fr) |
| CN (1) | CN101223129A (fr) |
| AR (1) | AR057662A1 (fr) |
| AU (1) | AU2006270380A1 (fr) |
| BR (1) | BRPI0613031A2 (fr) |
| CA (1) | CA2615362A1 (fr) |
| CR (1) | CR9661A (fr) |
| EC (1) | ECSP088104A (fr) |
| GT (1) | GT200600308A (fr) |
| IL (1) | IL188614A0 (fr) |
| MX (1) | MX2008000680A (fr) |
| NO (1) | NO20080006L (fr) |
| PE (1) | PE20070247A1 (fr) |
| RU (1) | RU2007149183A (fr) |
| TW (1) | TW200740724A (fr) |
| WO (1) | WO2007011594A2 (fr) |
| ZA (1) | ZA200800408B (fr) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060134210A1 (en) * | 2004-12-22 | 2006-06-22 | Astrazeneca Ab | Solid dosage form comprising proton pump inhibitor and suspension made thereof |
| WO2007067501A1 (fr) * | 2005-12-05 | 2007-06-14 | Wyeth | Procede pour la synthese selective d'enantiomeres de 1-(2-amino-1-phenyl-ethyl)-cyclohexanols substitues |
| MX2007016179A (es) | 2006-04-17 | 2008-03-11 | Teva Pharma | Formas cristalinas de o-desmetilvenlafaxina. |
| TW200806282A (en) * | 2006-05-05 | 2008-02-01 | Wyeth Corp | Solid dosage formulations |
| JP2008088159A (ja) * | 2006-07-26 | 2008-04-17 | Teva Pharmaceutical Industries Ltd | Ｏ−デスメチルベンラファキシンの合成方法 |
| US20090035370A1 (en) * | 2007-08-02 | 2009-02-05 | Drugtech Corporation | Dosage form and method of use |
| KR20100074303A (ko) | 2007-11-26 | 2010-07-01 | 테바 파마슈티컬 인더스트리즈 리미티드 | Ｏ-데스메틸벤라팍신 푸마레이트의 결정형 |
| US9339500B2 (en) * | 2008-03-04 | 2016-05-17 | Intra-Cellular Therapies, Inc. | Methods of treating vasomotor symptoms |
| US20100016638A1 (en) * | 2008-07-21 | 2010-01-21 | Zdenko Hamersak | Method for preparation of o-desmethylvenlafaxine using polythiolates |
| EP2496079A4 (fr) * | 2009-11-06 | 2014-05-14 | Pierre Fabre Médicament Sas | Nouvelles formes cristallines du (1s,2r)-2-(aminométhyl)-n,n-diéthyl-1-phénylcyclopropanecarboxamide |
| KR101409554B1 (ko) | 2010-03-29 | 2014-06-19 | 플리바 흐르바츠카 디.오.오. | Ｏ-데스메틸벤라팍신 푸마레이트의 결정형 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4535186A (en) * | 1983-04-19 | 1985-08-13 | American Home Products Corporation | 2-Phenyl-2-(1-hydroxycycloalkyl or 1-hydroxycycloalk-2-enyl)ethylamine derivatives |
| US6274171B1 (en) * | 1996-03-25 | 2001-08-14 | American Home Products Corporation | Extended release formulation of venlafaxine hydrochloride |
| JP4220243B2 (ja) * | 2001-02-12 | 2009-02-04 | ワイス | Ｏ−デスメチル−ベンラファキシンの新規コハク酸塩 |
| CA2554559A1 (fr) * | 2004-02-06 | 2005-08-25 | Wyeth | Sels d'o-desmethylvenlafaxines multiparticulaires et leurs utilisations |
| MX2007012167A (es) * | 2005-03-31 | 2007-11-22 | Wyeth Corp | Producto de combinacion de o-desmetilvenlafaxina y bazedoxifeno, y usos del mismo. |
-
2006
- 2006-07-13 MX MX2008000680A patent/MX2008000680A/es unknown
- 2006-07-13 EP EP06786969A patent/EP1904434A2/fr not_active Withdrawn
- 2006-07-13 AR ARP060103013A patent/AR057662A1/es unknown
- 2006-07-13 KR KR1020087003405A patent/KR20080034921A/ko not_active Withdrawn
- 2006-07-13 RU RU2007149183/04A patent/RU2007149183A/ru not_active Application Discontinuation
- 2006-07-13 TW TW095125667A patent/TW200740724A/zh unknown
- 2006-07-13 US US11/485,663 patent/US20070015828A1/en not_active Abandoned
- 2006-07-13 CA CA002615362A patent/CA2615362A1/fr not_active Abandoned
- 2006-07-13 CN CNA2006800258619A patent/CN101223129A/zh active Pending
- 2006-07-13 BR BRPI0613031-3A patent/BRPI0613031A2/pt not_active IP Right Cessation
- 2006-07-13 PE PE2006000834A patent/PE20070247A1/es not_active Application Discontinuation
- 2006-07-13 AU AU2006270380A patent/AU2006270380A1/en not_active Abandoned
- 2006-07-13 WO PCT/US2006/026991 patent/WO2007011594A2/fr not_active Ceased
- 2006-07-13 JP JP2008521551A patent/JP2009501229A/ja not_active Withdrawn
- 2006-07-19 GT GT200600308A patent/GT200600308A/es unknown
-
2007
- 2007-01-15 CR CR9661A patent/CR9661A/es not_active Application Discontinuation
-
2008
- 2008-01-02 NO NO20080006A patent/NO20080006L/no not_active Application Discontinuation
- 2008-01-06 IL IL188614A patent/IL188614A0/en unknown
- 2008-01-14 ZA ZA200800408A patent/ZA200800408B/xx unknown
- 2008-01-14 EC EC2008008104A patent/ECSP088104A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ECSP088104A (es) | 2008-04-28 |
| AR057662A1 (es) | 2007-12-12 |
| WO2007011594A3 (fr) | 2007-04-26 |
| AU2006270380A1 (en) | 2007-01-25 |
| TW200740724A (en) | 2007-11-01 |
| ZA200800408B (en) | 2008-12-31 |
| US20070015828A1 (en) | 2007-01-18 |
| IL188614A0 (en) | 2008-04-13 |
| EP1904434A2 (fr) | 2008-04-02 |
| PE20070247A1 (es) | 2007-04-11 |
| WO2007011594A2 (fr) | 2007-01-25 |
| KR20080034921A (ko) | 2008-04-22 |
| MX2008000680A (es) | 2008-03-14 |
| JP2009501229A (ja) | 2009-01-15 |
| GT200600308A (es) | 2007-04-10 |
| CA2615362A1 (fr) | 2007-01-25 |
| BRPI0613031A2 (pt) | 2012-01-03 |
| CR9661A (es) | 2008-03-07 |
| CN101223129A (zh) | 2008-07-16 |
| RU2007149183A (ru) | 2009-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20080006L (no) | Meget selektive serotonin og norepinefrin dobbelte reopptaksinhibitorer og deres anvendelse | |
| WO2007068797A3 (fr) | Procede de production d'un compose d'hydrocarbure ramifie | |
| EP1749818A3 (fr) | Dérivés de phenyl-piperazine en tant qu´inhibiteurs du recaptage de la serotonine | |
| PL2231577T3 (pl) | Proces produkcji cykloheksanonu za pomocą wielokrotnej destylacji następczej | |
| BR122017023795B8 (pt) | método para preparação de composição farmacêutica | |
| BRPI0810843A2 (pt) | Processo para a preparação de alcoóis etenilfenílicos oticamente ativos | |
| ATE486057T1 (de) | Verfahren zur herstellung von isocyanaten | |
| TW200801013A (en) | Substituted benzofused derivatives and their use as vanilloid receptor ligands | |
| NO20075635L (no) | Antigenbindende molekyler som har modifiserte Fc-regioner og endret binding til Fc-reseptorer | |
| ATE455752T1 (de) | Herstellung von (2r,3r)-3-(3-methoxyphenyl)-n,n,2-trimethylpent namin | |
| EP2578600A3 (fr) | Molécules à liaison spécifiques RSV et leur moyen de fabrication | |
| DE602006004109D1 (de) | Verbessertes Verfahren zur Herstellung von Schmierölen unter Verwendung von Doppelmetallcyanid-Katalysatoren | |
| BR112012013069A2 (pt) | processo para preparar isocianatos aromáticos. | |
| BRPI0816629A8 (pt) | processo contínuo de fabricação de compostos | |
| NZ592571A (en) | Aryl piperazine and their use as alpha2c antagonists | |
| BRPI0604821A (pt) | processo para preparação de 4,4'-difenilmetano diisocianato | |
| DE502004001542D1 (de) | Verfahren zur herstellung von ionischen flüssigkeiten mit alkylsulfat und funktionalisierten alkylsulfat-anionen | |
| EP3112338A3 (fr) | Dérivés de cyclohexène et leur utilisation comme substances odoriférantes | |
| BRPI0607793A2 (pt) | processo para a preparação de moduladores opióides | |
| ATE556997T1 (de) | Verfahren zur herstellung von aminen | |
| PA8781801A1 (es) | Derivados heteroarilo antidepresivos de benzodioxanos heterociclo-fusionados | |
| MY144543A (en) | Process for producing a branched hydrocarbon component | |
| EP1857434A3 (fr) | Procédé de production de xylylènediamine | |
| BR0209343A (pt) | Antidepressivos de azaheterociclilmetila derivados de [1,4]-benzodioxanos oxaheterociclo-fundidos; métodos de tratamento usando tais compostos; processo para prepará-los | |
| DE602005018532D1 (de) | Verfahren zur permanenten formung von haar mit einem kationischen zellulosederivat |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |